33/120
1.4 / 5 stars
All 120 Win/Lose results shown below
STIM Roast Me summary
Neuronetics, Inc. (STIM). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseSTIM / S&P -10.34% / 15.20% |
WinSTIM / S&P 39.59% / 15.00% |
LoseSTIM / S&P STIM unavailable / 50.40% |
| 2026-Q12/3 |
WinSTIM / S&P 5.07% / -4.33% |
WinSTIM / S&P 69.52% / 11.30% |
LoseSTIM / S&P STIM unavailable / 27.70% |
| 2025-Q41/3 |
LoseSTIM / S&P -49.45% / 2.65% |
WinSTIM / S&P 99.17% / 9.00% |
LoseSTIM / S&P STIM unavailable / 13.40% |
| 2025-Q31/3 |
LoseSTIM / S&P -21.78% / 8.12% |
WinSTIM / S&P 78.62% / 4.61% |
LoseSTIM / S&P STIM unavailable / 13.45% |
| 2025-Q21/3 |
LoseSTIM / S&P -5.16% / 10.94% |
WinSTIM / S&P 54.17% / 4.83% |
LoseSTIM / S&P STIM unavailable / 10.63% |
| 2025-Q12/3 |
WinSTIM / S&P 128.57% / -4.27% |
WinSTIM / S&P 22.16% / 4.98% |
LoseSTIM / S&P STIM unavailable / 10.57% |
| 2024-Q41/3 |
WinSTIM / S&P 111.84% / 2.41% |
LoseSTIM / S&P 4.96% / 5.25% |
LoseSTIM / S&P STIM unavailable / 6.15% |
| 2024-Q30/3 |
LoseSTIM / S&P -57.78% / 5.89% |
LoseSTIM / S&P 5.03% / 5.89% |
LoseSTIM / S&P STIM unavailable / 6.11% |
| 2024-Q21/3 |
LoseSTIM / S&P -62.18% / 4.28% |
WinSTIM / S&P 6.22% / 5.38% |
LoseSTIM / S&P STIM unavailable / 5.12% |
| 2024-Q12/3 |
WinSTIM / S&P 64.14% / 10.56% |
WinSTIM / S&P 10.01% / 5.71% |
LoseSTIM / S&P STIM unavailable / 5.59% |
| 2023-Q42/3 |
WinSTIM / S&P 114.81% / 11.69% |
WinSTIM / S&P 9.42% / 6.81% |
LoseSTIM / S&P STIM unavailable / 7.78% |
| 2023-Q31/3 |
LoseSTIM / S&P -37.21% / -3.27% |
WinSTIM / S&P 11.61% / 7.52% |
LoseSTIM / S&P STIM unavailable / -5.03% |
| 2023-Q21/3 |
LoseSTIM / S&P -26.12% / 8.74% |
WinSTIM / S&P 14.35% / 9.50% |
LoseSTIM / S&P STIM unavailable / -8.57% |
| 2023-Q11/3 |
LoseSTIM / S&P -57.64% / 7.50% |
WinSTIM / S&P 16.36% / 10.77% |
LoseSTIM / S&P STIM unavailable / -15.69% |
| 2022-Q42/3 |
WinSTIM / S&P 116.04% / 7.56% |
WinSTIM / S&P 17.89% / 11.88% |
LoseSTIM / S&P STIM unavailable / -17.99% |
| 2022-Q31/3 |
WinSTIM / S&P -0.93% / -4.88% |
LoseSTIM / S&P 11.03% / 13.47% |
LoseSTIM / S&P STIM unavailable / -1.41% |
| 2022-Q21/3 |
WinSTIM / S&P 5.94% / -16.10% |
LoseSTIM / S&P 8.83% / 13.71% |
LoseSTIM / S&P STIM unavailable / 11.04% |
| 2022-Q10/3 |
LoseSTIM / S&P -32.06% / -4.60% |
LoseSTIM / S&P 14.28% / 15.97% |
LoseSTIM / S&P STIM unavailable / 42.23% |
| 2021-Q40/3 |
LoseSTIM / S&P -32.01% / 11.03% |
LoseSTIM / S&P 12.32% / 15.00% |
LoseSTIM / S&P STIM unavailable / 96.40% |
| 2021-Q30/3 |
LoseSTIM / S&P -59.05% / 0.58% |
LoseSTIM / S&P 9.50% / 10.77% |
LoseSTIM / S&P STIM unavailable / 69.42% |
| 2021-Q21/3 |
WinSTIM / S&P 29.51% / 8.55% |
LoseSTIM / S&P -0.10% / 6.58% |
LoseSTIM / S&P STIM unavailable / 51.81% |
| 2021-Q11/3 |
WinSTIM / S&P 11.34% / 6.17% |
LoseSTIM / S&P -18.48% / -1.06% |
LoseSTIM / S&P STIM unavailable / 7.39% |
| 2020-Q41/3 |
WinSTIM / S&P 128.60% / 12.15% |
LoseSTIM / S&P -21.41% / -3.72% |
LoseSTIM / S&P STIM unavailable / -33.42% |
| 2020-Q31/3 |
WinSTIM / S&P 151.81% / 8.93% |
LoseSTIM / S&P -16.27% / -2.04% |
LoseSTIM / S&P STIM unavailable / -27.10% |
| 2020-Q20/3 |
LoseSTIM / S&P 2.12% / 20.54% |
LoseSTIM / S&P -6.99% / -0.46% |
LoseSTIM / S&P STIM unavailable / -27.11% |
| 2020-Q11/3 |
LoseSTIM / S&P -57.91% / -19.60% |
WinSTIM / S&P 10.93% / 3.47% |
LoseSTIM / S&P STIM unavailable / -14.75% |
| 2019-Q41/3 |
LoseSTIM / S&P -45.97% / 9.07% |
WinSTIM / S&P 18.72% / 5.36% |
LoseSTIM / S&P STIM unavailable / 2.99% |
| 2019-Q31/3 |
LoseSTIM / S&P -33.57% / 1.70% |
WinSTIM / S&P 23.73% / 5.02% |
LoseSTIM / S&P STIM unavailable / 0.21% |
| 2019-Q21/3 |
LoseSTIM / S&P -17.97% / 4.30% |
WinSTIM / S&P 27.54% / 6.64% |
LoseSTIM / S&P STIM unavailable / 8.65% |
| 2019-Q11/3 |
LoseSTIM / S&P -21.19% / 13.65% |
WinSTIM / S&P 28.55% / 8.12% |
LoseSTIM / S&P STIM unavailable / 14.29% |
| 2018-Q41/3 |
LoseSTIM / S&P -39.64% / -13.52% |
WinSTIM / S&P 30.53% / 9.05% |
LoseSTIM / S&P STIM unavailable / 18.23% |
| 2018-Q31/3 |
WinSTIM / S&P 20.48% / 7.71% |
LoseSTIM / S&P STIM unavailable / 10.21% |
LoseSTIM / S&P STIM unavailable / 19.06% |
| 2018-Q20/3 |
LoseSTIM / S&P STIM unavailable / 3.43% |
LoseSTIM / S&P STIM unavailable / 9.03% |
LoseSTIM / S&P STIM unavailable / 14.46% |
| 2018-Q10/3 |
LoseSTIM / S&P STIM unavailable / -0.76% |
LoseSTIM / S&P STIM unavailable / 7.68% |
LoseSTIM / S&P STIM unavailable / 12.46% |
| 2017-Q41/3 |
LoseSTIM / S&P STIM unavailable / 6.64% |
WinSTIM / S&P 18.13% / 7.03% |
LoseSTIM / S&P STIM unavailable / 13.82% |
| 2017-Q30/3 |
LoseSTIM / S&P STIM unavailable / 4.48% |
LoseSTIM / S&P STIM unavailable / 5.68% |
LoseSTIM / S&P STIM unavailable / 17.57% |
| 2017-Q20/3 |
LoseSTIM / S&P STIM unavailable / 3.09% |
LoseSTIM / S&P STIM unavailable / 4.83% |
LoseSTIM / S&P STIM unavailable / 17.74% |
| 2017-Q10/3 |
LoseSTIM / S&P STIM unavailable / 6.07% |
LoseSTIM / S&P STIM unavailable / 3.67% |
LoseSTIM / S&P STIM unavailable / 13.32% |
| 2016-Q40/3 |
LoseSTIM / S&P STIM unavailable / 3.82% |
LoseSTIM / S&P STIM unavailable / 2.09% |
LoseSTIM / S&P STIM unavailable / 7.05% |
| 2016-Q30/3 |
LoseSTIM / S&P STIM unavailable / 3.85% |
LoseSTIM / S&P STIM unavailable / 0.20% |
LoseSTIM / S&P STIM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | STIM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -12.16% | 20.78% |
| Annualized return | -12.16% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | STIM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -61.36% | 83.14% |
| Annualized return | -17.32% | 12.86% |
10Y · 2018-06-28 to 2026-08-28
| Metric | STIM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.47% | 319.30% |
| Annualized return | -20.16% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |